Evidence map›Paper›PMID 37208126›Full record

ArticleJournal of psychiatry & neuroscience : JPN

Association between retinal and cortical visual electrophysiological impairments in schizophrenia.

Irving Remy, Florent Bernardin, Fabienne Ligier, Julien Krieg, Louis Maillard, Raymund Schwan, Thomas Schwitzer, Vincent Laprévote

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Journal of psychiatry & neuroscience : JPN. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02864680 (Electrophysiological Study of the Functioning of Magnocellular Visual Pathway in Regular Cannabis Users), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02864680 nacompletednot on this map

Electrophysiological Study of the Functioning of Magnocellular Visual Pathway in Regular Cannabis Users

TypeinterventionalSponsorCentral Hospital, Nancy, FranceRan2014 to 2019Enrolled163ConditionsCannabis UseArmsElectroretinography, Contrast sensitivity test during Electroencephalography, Visual simultaneity test during Electroencephalography, Face perception test during Electroencephalography, CAST (cannabis abuse screening test)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Irving RemyFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Florent BernardinFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Fabienne LigierFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Julien KriegFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Louis MaillardFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Raymund SchwanFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Thomas SchwitzerFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy).
Vincent LaprévoteFrom the Centre Psychothérapique de Nancy, Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes du Grand Nancy, Laxou, France (Remy, Bernardin, Krieg, Schwan, Schwitzer, Laprévote); the INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France (Remy, Bernardin, Krieg, Laprévote); the Centre Psychothérapique de Nancy, Pôle Universitaire de Psychiatrie de l'Enfant et de l'Adolescent, Laxou, France (Ligier); the Université de Lorraine, EA 4360 APEMAC, Equipe MICS, Nancy, France (Ligier); the Université de Lorraine, CNRS, CRAN, UMR 7039, Vandœuvre-lès-Nancy, France (Maillard); the Service de Neurologie, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France (Maillard); the Université de Lorraine, IADI, INSERM U1254, Vandœuvre-lès-Nancy, France (Schwan, Schwitzer); BioSerenity, 47 Boulevard de l'Hôpital, ICM-IPEPS, Paris, France (Remy) vincent.laprevote@cpn-laxou.com.
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElectrophysiological impairments in the magnocellular visual system have been reported among patients with schizophrenia, but previous theories proposed that these deficits may begin in the retina. We therefore sought to evaluate the potential contribution of the retina by comparing retinal and cortical visual electrophysiological impairments between patients with schizophrenia and healthy controls.

methodsWe recruited patients with schizophrenia and age- and sex-matched healthy controls. We recorded the P100 amplitude and latency using electroencephalography (EEG) while projecting low (0.5 cycles/degree) or high (15 cycles/degree) spatial frequency gratings at a temporal frequency of 0 Hz or 8 Hz. We compared the P100 results with previous results for retinal ganglion cell activity (N95) in these participants. We analyzed data using repeated-measures analysis of variance and correlation analyses.

resultsWe recruited 21 patients with schizophrenia and 29 age- and sex-matched healthy controls. Results showed decreased P100 amplitude and increased P100 latency among patients with schizophrenia compared with healthy controls ( DISCUSSION: Alterations in the P100 wave among patients with schizophrenia are consistent with the deficits in early visual cortical processing shown in the literature. These deficits do not seem to correspond to an isolated magnocellular deficit but appear to be associated with previous retinal measurements. Such an association emphasizes the role of the retina in the occurrence of visual cortical abnormalities in schizophrenia. Studies with coupled electroretinography-EEG measurements are now required to further explore these findings. CLINICAL TRIALS REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT02864680.

Indexed as

SchizophreniaElectroencephalographyEvoked Potentials, VisualHumansRetina

Identifiers

PMID37208126
PMCPMC10205822
OpenAlexW4377092192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.